April 30th 2025
Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar gaps, reimbursement pressure from GLP-1s, and persistent access challenges.
Democratizing AI: Bridging the Intelligence Divide in Commercial Life Sciences
March 14th 2022Small and emerging biopharma have been historically reserved about artificial intelligence. But, writes Alan Kalton, AI solutions have matured, been proven, and are no longer a risky investment for small to mid-size companies.
Pharma & Big Data: New Heights Beckon
November 17th 2021Ongoing strides in data mining, data analytics, modeling and simulation are opening up new and more definitive opportunities to apply data-driven insights to improve everything from upstream drug discovery and clinical trials, to the downstream go-to-market strategy and post-patent lifecycle management